Showing results (31-40 of 116) with videos related to
Sort By:
Pageof 12
Advances in Experimental Medicine and Biology|January 1, 1991
Abnormal brain glucose metabolism in Alzheimer's disease, as measured by position emission tomographyS I Rapoport, B Horwitz, C L Grady, et al.Journal of Intellectual Disability Research : JIDR|August 22, 2013
Functional magnetic resonance imaging of story listening in adolescents and young adults with Down syndrome: evidence for atypical neurodevelopmentL M Jacola, A W Byars, F Hickey, et al.Neurology|March 1, 1990
Cerebrospinal fluid production is reduced in healthy agingC May, J A Kaye, J R Atack, et al.International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|February 1, 1993
Laminin concentrations in serum and cerebrospinal fluid in aging and Alzheimer's diseaseS D Kittur, W H Adler, G R Martin, et al.Neurology|August 1, 1987
Quantitative CT analysis of brain morphometry in adult Down's syndrome at different agesM B Schapiro, H Creasey, M Schwartz, et al.Alzheimer Disease and Associated Disorders|June 18, 1999
Neuroendocrine responses to intravenous infusion of physostigmine in patients with Alzheimer diseaseS Asthana, K C Raffaele, N H Greig, et al.Annals of Neurology|April 1, 1987
Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndromeA D Kay, M B Schapiro, A K Riker, et al.Archives of Neurology|March 3, 1998
Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysisH Hampel, S J Teipel, G E Alexander, et al.Annals of Internal Medicine|August 15, 1988
NIH conference. Alzheimer disease: clinical and biological heterogeneityR P Friedland, E Koss, J V Haxby, et al.Neurology|June 1, 1988
Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathologyM B Schapiro, M J Ball, C L Grady, et al.Pageof 12